PSCR Stock Overview
Proto Script Pharmaceutical Corp. engages in the repair and rental of power wheelchairs and scooters.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Proto Script Pharmaceutical Corp. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.0002 |
| 52 Week High | US$0.005 |
| 52 Week Low | US$0.000001 |
| Beta | 0 |
| 1 Month Change | 19,900.00% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | -96.08% |
| 5 Year Change | -88.89% |
| Change since IPO | -99.85% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
| PSCR | US Healthcare | US Market | |
|---|---|---|---|
| 7D | 0% | 6.5% | -3.2% |
| 1Y | n/a | 4.0% | 19.3% |
Return vs Industry: Insufficient data to determine how PSCR performed against the US Healthcare industry.
Return vs Market: Insufficient data to determine how PSCR performed against the US Market.
Price Volatility
| PSCR volatility | |
|---|---|
| PSCR Average Weekly Movement | n/a |
| Healthcare Industry Average Movement | 6.9% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.5% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: PSCR's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine PSCR's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2001 | n/a | Michelle Rico | www.psphomecare.com |
Proto Script Pharmaceutical Corp. engages in the repair and rental of power wheelchairs and scooters. The company serves federal, state, and private insurance providers. Proto Script Pharmaceutical Corp. was founded in 2001 and is headquartered in Rancho Cucamonga, California.
Proto Script Pharmaceutical Corp. Fundamentals Summary
| PSCR fundamental statistics | |
|---|---|
| Market cap | US$11.38k |
| Earnings (TTM) | -US$8.39m |
| Revenue (TTM) | US$604.98k |
0.0x
P/S Ratio0.0x
P/E RatioIs PSCR overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| PSCR income statement (TTM) | |
|---|---|
| Revenue | US$604.98k |
| Cost of Revenue | US$253.17k |
| Gross Profit | US$351.81k |
| Other Expenses | US$8.74m |
| Earnings | -US$8.39m |
Last Reported Earnings
Sep 30, 2017
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did PSCR perform over the long term?
See historical performance and comparison